In conclusion, the JNK and NF-κB pathways are crucial in MASLD-related liver cancer, representing promising targets for the development of novel diagnostic and therapeutic approaches. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.